Namodenoson
Tier C — Watch / tradeNamodenoson
Targets：ADORA3
Indications (approved)：Hepatocellular carcinoma, Liver cirrhosis, Non-alcoholic steatohepatitis, Pancreatic cancer, Chronic hepatitis C
Regional status
Synthetic routes & intermediates1 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
| Code | CAS No. | Intermediate |
|---|---|---|
| NAMOD-001 | 13039-63-9 | (2R,3S,4R)-2-(hydroxymethyl)-5-methoxytetrahydrofuran-3,4-diol |
| NAMOD-002 | 1628567-06-5 | (2R,3S,4R)-2-(((tert-butyldiphenylsilyl)oxy)methyl)-5-methoxytetrahydrofuran-3,4-diol |
| NAMOD-003 | - | (2R,3R,4R)-2-(((tert-butyldiphenylsilyl)oxy)methyl)-5-methoxytetrahydrofuran-3,4-diyl dibenzoate |
| NAMOD-004 | - | (2R,3R,4R)-2-(hydroxymethyl)-5-methoxytetrahydrofuran-3,4-diyl dibenzoate |
| NAMOD-005 | - | (2S,3S,4R)-3,4-bis(benzoyloxy)-5-methoxytetrahydrofuran-2-carboxylic acid |
| NAMOD-006 | - | (3R,4S,5S)-2-methoxy-5-(methoxycarbonyl)tetrahydrofuran-3,4-diyl dibenzoate |
| NAMOD-007 | - | (3R,4S,5S)-2-methoxy-5-(methylcarbamoyl)tetrahydrofuran-3,4-diyl dibenzoate |
| NAMOD-008 | - | (3R,4S,5S)-2-acetoxy-5-(methylcarbamoyl)tetrahydrofuran-3,4-diyl dibenzoate |
| NAMOD-009 | 120046-86-8 | 2-chloro-N-(3-iodobenzyl)-9H-purin-6-amine |
| NAMOD-010 | 163042-90-8 | (2R,3R,4S,5S)-2-(2-chloro-6-((3-iodobenzyl)amino)-9H-purin-9-yl)-5-(methylcarbamoyl)tetrahydrofuran-3,4-diyl dibenzoate |
| NAMOD-011 | 5451-40-1 | 2,6-dichloro-9H-purine |
| NAMOD-012 | 3718-88-5 | (3-iodophenyl)methanamine hydrochloride |
| Namodenoson | 163042-96-4 | - |
Frequently asked questions
What are the approved indications of Namodenoson?
Approved indications include: Hepatocellular carcinoma, Liver cirrhosis, Non-alcoholic steatohepatitis, Pancreatic cancer, Chronic hepatitis C.
When does the Namodenoson patent expire?
No public expiry year is available for Namodenoson yet; this page updates once verified.
How many synthesis routes are recorded for Namodenoson?
1 synthesis routes are recorded; the shortest is 11 steps with 13.4 mg total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy Namodenoson intermediates?
All intermediates in Namodenoson routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.
How do I get a quote for Namodenoson intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-03